• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

镰状细胞疾病扫描检测系统(BioMedomics公司)满足镰状细胞病新生儿筛查的分析条件。

Sickle SCAN™ (BioMedomics) fulfills analytical conditions for neonatal screening of sickle cell disease.

作者信息

Nguyen-Khoa Thao, Mine Louis, Allaf Bichr, Ribeil Jean-Antoine, Remus Christelle, Stanislas Aurélie, Gauthereau Valérie, Enouz Sarah, Kim Jason S, Yang Xiaoxi, Gluckman Eliane, Beaudeux Jean-Louis, Munnich Arnold, Girot Robert, Cavazzana Marina

机构信息

Service de biochimie générale, Hôpital universitaire Necker-Enfants malades, AP-HP, Paris, France.

Unité de dépistage néonatal de la drépanocytose et des hémoglobinopathies, Laboratoire de biochimie hormonologie, Hôpital Robert Debré, AP-HP, Paris, France.

出版信息

Ann Biol Clin (Paris). 2018 Aug 1;76(4):416-420. doi: 10.1684/abc.2018.1354.

DOI:10.1684/abc.2018.1354
PMID:29976532
Abstract

Sickle SCAN™ is a rapid, qualitative, point-of-care lateral flow immunoassay for the identification of AS, AC, SS/Sβthal, SC and CC/Cβthal phenotype. We evaluated this test under the conditions encountered in the French newborn screening (NBS) program for sickle cell disease: a total of 104 dried blood spots (DBSs) were tested with an HPLC reference method and then with the Sickle SCAN™ device. Sickle SCAN™ identified the hemoglobin (Hb) phenotype correctly on 96% of cases. In the four non-concordant cases, the antibody anti-HbS cross-reacted with HbE (n=2), HbD (n=1) or HbX (n=1). There were no false negative. In order to test Sickle SCAN™'s sensitivity to low levels of HbA and HbS in the presence of high HbF levels, we selected another 21 DBS cards with low percentages of HbA (0.6-4.2%) and HbS (2.0-6.9%). HbA and HbS were always detected when present at levels of more than 1% and 2%, respectively. Sickle SCAN™ appears to be an accurate point-of-care method for the identification of newborns with SCD trait. The device meets the criteria for sickle cell disease NBS programs in endemic countries with poor access to laboratory equipment.

摘要

镰状细胞检测扫描™(Sickle SCAN™)是一种快速、定性的即时检测侧向流动免疫分析法,用于鉴定AS、AC、SS/Sβ地中海贫血、SC和CC/Cβ地中海贫血表型。我们在法国镰状细胞病新生儿筛查(NBS)项目所遇到的条件下对该检测方法进行了评估:总共104份干血斑(DBS)先用高效液相色谱(HPLC)参考方法进行检测,然后再用镰状细胞检测扫描™设备进行检测。镰状细胞检测扫描™在96%的病例中正确鉴定出了血红蛋白(Hb)表型。在4例不一致的病例中,抗-HbS抗体与HbE(n = 2)、HbD(n = 1)或HbX(n = 1)发生了交叉反应。没有假阴性结果。为了测试镰状细胞检测扫描™在高HbF水平存在时对低水平HbA和HbS的敏感性,我们又选择了另外21张HbA百分比低(0.6 - 4.2%)和HbS百分比低(2.0 - 6.9%)的DBS卡片。当HbA和HbS水平分别超过1%和2%时,总能检测到它们。镰状细胞检测扫描™似乎是一种用于鉴定患有镰状细胞病特征新生儿的准确即时检测方法。该设备符合在难以获得实验室设备的流行国家开展镰状细胞病NBS项目的标准。

相似文献

1
Sickle SCAN™ (BioMedomics) fulfills analytical conditions for neonatal screening of sickle cell disease.镰状细胞疾病扫描检测系统(BioMedomics公司)满足镰状细胞病新生儿筛查的分析条件。
Ann Biol Clin (Paris). 2018 Aug 1;76(4):416-420. doi: 10.1684/abc.2018.1354.
2
New approach to accurate interpretation of sickle cell disease newborn screening by applying multiple of median cutoffs and ratios.应用中位数倍数和比值的新方法准确解读镰状细胞病新生儿筛查
Pediatr Blood Cancer. 2018 Sep;65(9):e27230. doi: 10.1002/pbc.27230. Epub 2018 May 21.
3
Strategy linking several analytical methods of neonatal screening for sickle cell disease.镰状细胞病新生儿筛查多种分析方法的联用策略
J Med Screen. 2001;8(1):8-14. doi: 10.1136/jms.8.1.8.
4
Validation of a novel point of care testing device for sickle cell disease.一种新型镰状细胞病即时检测设备的验证
BMC Med. 2015 Sep 16;13:225. doi: 10.1186/s12916-015-0473-6.
5
[Targeted newborn screening for sickle-cell anemia: Sickling test (Emmel test) boundaries in the prenatal assessment in West African area].[镰状细胞贫血的新生儿靶向筛查:西非地区产前评估中的镰变试验(埃默尔试验)界限]
Rev Epidemiol Sante Publique. 2018 May;66(3):181-185. doi: 10.1016/j.respe.2018.02.007. Epub 2018 Apr 4.
6
A rapid, inexpensive and disposable point-of-care blood test for sickle cell disease using novel, highly specific monoclonal antibodies.一种使用新型、高度特异性单克隆抗体的用于镰状细胞病的快速、廉价且一次性即时检测血液测试。
Br J Haematol. 2016 Nov;175(4):724-732. doi: 10.1111/bjh.14298. Epub 2016 Sep 8.
7
Characteristics of a rapid, point-of-care lateral flow immunoassay for the diagnosis of sickle cell disease.用于诊断镰状细胞病的即时快速侧向流动免疫测定法的特点。
Am J Hematol. 2016 Feb;91(2):205-10. doi: 10.1002/ajh.24232. Epub 2015 Nov 26.
8
Screening for sickle cell disease on dried blood: a new approach evaluated on 27,000 Belgian newborns.干血片镰状细胞病筛查:在27000名比利时新生儿中评估的一种新方法。
J Med Screen. 2006;13(3):132-6. doi: 10.1258/096914106778440644.
9
MALDI-MS in first-line screening of newborns for sickle cell disease: results from a prospective study in comparison to HPLC.MALDI-MS 在新生儿镰状细胞病一线筛查中的应用:与 HPLC 比较的前瞻性研究结果。
Clin Chem Lab Med. 2024 Feb 5;62(6):1149-1157. doi: 10.1515/cclm-2023-1250. Print 2024 May 27.
10
Newborn screening for sickle cell disorders using tandem mass spectrometry: three years' experience of using a protocol to detect only the disease states.使用串联质谱法对镰状细胞疾病进行新生儿筛查:三年来仅检测疾病状态方案的应用经验。
Ann Clin Biochem. 2017 Sep;54(5):601-611. doi: 10.1177/0004563217713788. Epub 2017 Jul 17.

引用本文的文献

1
CRISPR genome editing using a combined positive and negative selection system.使用正反向选择系统组合的CRISPR基因组编辑
PLoS One. 2025 May 6;20(5):e0321881. doi: 10.1371/journal.pone.0321881. eCollection 2025.
2
Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020-2023).《2024年全球新生儿血斑筛查现状:2020 - 2023年近期活动综合回顾》
Int J Neonatal Screen. 2024 May 23;10(2):38. doi: 10.3390/ijns10020038.
3
Implementation of hospital-based sickle cell newborn screening and follow-up programs in Haiti.
在海地实施基于医院的镰状细胞新生儿筛查和随访计划。
Blood Adv. 2024 Jan 9;8(1):14-22. doi: 10.1182/bloodadvances.2023010104.
4
Using dried blood spot on HemoTypeSC™, a new frontier for newborn screening for sickle cell disease in Nigeria.利用HemoTypeSC™干血斑,这是尼日利亚镰状细胞病新生儿筛查的新前沿。
Front Genet. 2022 Oct 26;13:1013858. doi: 10.3389/fgene.2022.1013858. eCollection 2022.
5
Evaluation of Paper-Based Point of Care Screening Test for Sickle Cell Disease.镰状细胞病纸质即时检验筛查试验的评估
Indian J Clin Biochem. 2022 Apr;37(2):185-191. doi: 10.1007/s12291-021-00962-5. Epub 2021 Feb 8.
6
Trends in the Development of Diagnostic Tools for Red Blood Cell-Related Diseases and Anemias.红细胞相关疾病和贫血诊断工具的发展趋势
Front Physiol. 2020 May 26;11:387. doi: 10.3389/fphys.2020.00387. eCollection 2020.